Colgate-Palmolive (CL) Stock

Colgate-Palmolive's shares fell today after the company did not meet expectations in its fourth-quarter earnings report and provided a disappointing forecast.

CL's results for the fourth quarter indicate ongoing increases in both volume and pricing, resulting in organic sales growth in five out of six divisions. The rise in gross margins also contributes to the growth in earnings per share (EPS).

Colgate-Palmolive Company (NYSE:CL) will hold its Q4 2024 Earnings Conference Call on January 31, 2025, at 8:30 AM ET. The call will feature key company leaders, including John Faucher, Noel Wallace, and Stanley Sutula, along with various participants from major financial institutions. The operator will begin the call by welcoming everyone to the conference.

Colgate-Palmolive (CL) reported quarterly earnings of $0.91 per share, which is higher than the Zacks Consensus Estimate of $0.89 per share. This is an increase compared to last year's earnings of $0.87 per share.

The CEO of Colgate-Palmolive mentioned that the company reached an "exciting milestone," but this news did not help boost the stock price in premarket trading.

Toothpaste company Colgate-Palmolive predicted that its yearly sales will be lower than what Wall Street expected, after falling short of quarterly sales estimates on Friday. This decline is due to low demand for its household products in North America and Latin America.

Colgate-Palmolive Company CL is set to announce its fourth-quarter earnings results on Friday, January 31, 2025, before the market opens.

Colgate-Palmolive's stock price is experiencing a significant drop as investors anticipate the fourth-quarter results. The stock has fallen more than 17%, resulting in a market value of around $73 billion.

CL's Q4 results are likely to show benefits from pricing, funding growth, and other productivity efforts, which will help maintain strong business momentum.